Nationwide multi-institutional retrospective analysis of high-dose-rate brachytherapy combined with external beam radiotherapy for localized prostate cancer: An Asian Prostate HDR-BT Consortium

• Published in: Brachytherapy Vol. 16; no. 3; pp. 503 - 510
• Main Authors: Ishiyama, Hiromichi, Kamitani, Nobuhiko, Kawamura, Hidemasa, Kato, Shingo, Aoki, Manabu, Kariya, Shinji, Matsumura, Taisei, Kaidu, Motoki, Yoshida, Ken, Hashimoto, Yaichiro, Noda, Yasutaka, Lim, Keith H.C., Kawase, Takatsugu, Takahashi, Takeo, Inaba, Koji, Kumano, Motoyasu, Yoshikawa, Nobuhiko, Yoshioka, Yasuo, Nakamura, Katsumasa, Hiratsuka, Junichi, Itami, Jun, Hayakawa, Kazushige
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.05.2017
• Subjects: Aged; Androgen Antagonists - therapeutic use; Androgen deprivation therapy; Brachytherapy; Brachytherapy - adverse effects; Chemotherapy, Adjuvant; Disease-Free Survival; Follow-Up Studies; Gastrointestinal Diseases - etiology; Hematology, Oncology and Palliative Medicine; High dose rate; Humans; Japan; Male; Male Urogenital Diseases - etiology; Middle Aged; Neoadjuvant Therapy; Prostate cancer; Prostate-Specific Antigen - blood; Prostatic Neoplasms - blood; Prostatic Neoplasms - pathology; Prostatic Neoplasms - therapy; Radiology; Radiotherapy Dosage; Retrospective Studies; Risk Factors; Survival Rate; Treatment Outcome; Whole pelvic irradiation; Brachytherapy; Androgen deprivation therapy; Whole pelvic irradiation; Prostate cancer; High dose rate

To report outcomes and risk factors of high-dose-rate (HDR) brachytherapy combined with external beam radiotherapy with or without androgen deprivation therapy (ADT) in prostate cancer patients. This multi-institutional retrospective analysis comprised 3424 patients with localized prostate cancer at...